| Ytd | -39.46% | |
| 1y | -39.52% |
| Open | 11.11 | Prev Close | 11.13 | Low | 10.93 | High | 11.23 | Mkt Cap | 1.07B |
| Vol | 6.53K | Avg Vol | 800.35K | EPS | -0.51 | P/E | -21.65 | Forward P/E | 13.33 |
| Beta | N/A | Short Ratio | 3.42 | Inst. Own | 34.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 9.61 | 200-d Avg | 12.05 | 1yr Est | 17.29 |
Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation
Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging servic
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lo
Lumexa Imaging Holdings (NASDAQ:LMRI) is looking for FY2026 Adj EPS of $0.71-$0.77 vs $0.73 analyst
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.18 per share which beat the
Barclays analyst Andrew Mok maintains Lumexa Imaging Hldgs (NASDAQ:LMRI) with a Overweight and lo
On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visi
Lumexa Imaging Holdings (NASDAQ:LMRI) sees FY2026 sales of $1.045 billion-$1.097 billion vs $1.066 b
Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly losses of $(0.20) per share which missed th
Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per